Franco M Piazza Selected Research

Polyproteins

10/2010	A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis.
9/2010	A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franco M Piazza Research Topics

Disease

3	Leishmaniasis 01/2012 - 12/2009
2	Infections 01/2021 - 04/2011
2	Cutaneous Leishmaniasis 09/2010 - 12/2009
1	Meningococcal Infections 12/2022
1	Clostridium Infections 01/2021
1	Visceral Leishmaniasis (Kala Azar) 04/2011
1	Asymptomatic Infections 12/2009
1	Hypersensitivity (Allergy) 12/2009
1	Congenital Heart Defects (Congenital Heart Defect) 10/2003

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2021 - 12/2009
2	PolyproteinsIBA 10/2010 - 09/2010
1	Conjugate VaccinesIBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	ToxoidsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2010
1	Meglumine AntimoniateIBA 09/2010
1	Palivizumab FDA Link 10/2003

Therapy/Procedure

2	Injections 10/2010 - 09/2010
1	Length of Stay 01/2021